Immunogenicity 13502
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
PCDHA6
Transcript ID
uc011dab.2
HLA INFO
C*12:03
TCR INFO
No TCR info found!
Full length protein sequence (803 aa)
MVFTP
1
EDRLG
6
KQCLL
11
LPLLL
16
LAAWK
21
VGSGQ
26
LHYSV
31
PEEAK
36
HGTFV
41
GRIAQ
46
DLGLE
51
LAELV
56
PRLFR
61
MASKD
66
REDLL
71
EVNLQ
76
NGILF
81
VNSRI
86
DREEL
91
CGRSA
96
ECSIH
101
LEVIV
106
DRPLQ
111
VFHVD
116
VEVRD
121
INDNP
126
PLFPV
131
EEQRV
136
LIYES
141
RLPDS
146
VFPLE
151
GASDA
156
DVGSN
161
SILTY
166
KLSSS
171
EYFGL
176
DVKIN
181
SDDNK
186
QIGLL
191
LKKSL
196
DREEA
201
PAHNL
206
FLTAT
211
DGGKP
216
ELTGT
221
VQLLV
226
TVLDV
231
NDNAP
236
TFEQS
241
EYEVR
246
IFENA
251
DNGTT
256
VIRLN
261
ASDRD
266
EGANG
271
AISYS
276
FNSLV
281
AAMVI
286
DHFSI
291
DRNTG
296
EIVIR
301
GNLDF
306
EQENL
311
YKILI
316
DATDK
321
GHPPM
326
AGHCT
331
VLVRI
336
LDKND
341
NVPEI
346
ALTSL
351
SLPVR
356
EDAQF
361
GTVIA
366
LISVN
371
DLDSG
376
ANGQV
381
NCSLT
386
PHVPF
391
KLVST
396
FKNYY
401
SLVLD
406
SALDR
411
ESVSA
416
YELVV
421
TARDG
426
GSPSL
431
WATAS
436
LSVEV
441
ADMND
446
NAPAF
451
AQPEY
456
TVFVK
461
ENNPP
466
GCHIF
471
TVSAR
476
DADAQ
481
ENALV
486
SYSLV
491
ERRVG
496
ERALS
501
SYISV
506
HAESG
511
KVYAL
516
QPLDH
521
EELEL
526
LQFQV
531
SARDA
536
GVPPL
541
GSNVT
546
LQVFV
551
LDEND
556
NAPAL
561
LAPRV
566
GGTGG
571
AVSEL
576
VPRSL
581
GAGQV
586
VAKVR
591
AVDAD
596
SGYNA
601
WLSYE
606
LQPPA
611
SSARF
616
PFRVG
621
LYTGE
626
ISTTR
631
VLDEA
636
DSPRH
641
RLLVL
646
VKDHG
651
EPALT
656
ATATV
661
LVSLV
666
ESGQA
671
PKASS
676
RASVG
681
AAGPE
686
AALVD
691
VNVYL
696
IIAIC
701
AVSSL
706
LVLTL
711
LLYTA
716
LRCSA
721
PPTEG
726
ACTAD
731
KPTLV
736
CSSAV
741
GSWSY
746
SQQRR
751
QRVCS
756
GEGPP
761
KMDLM
766
AFSPS
771
LSPCP
776
IMMGK
781
AENQD
786
LNEDH
791
DAKVS
796
EFS
801
Mutation Information
DNA mutation:
None
Peptide Range:
181 ~ 205
Mut AA position:
193 (13 in Wild Type peptide)
Alignment
Wild Type:
"DVKINSDDNKQIGLLLKKSLDREEA
||||||||||||.||||||||||||
Mutant:
DVKINSDDNKQIRLLLKKSLDREEA"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) PCDHA6
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay